Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report

Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report

Background: Salivary duct carcinoma (SDC), an aggressive and rare malignancy with poor prognosis, is mostly associated with the overexpression of the androgen receptor (AR) and human epidermal growth factor receptor 2 (HER2). However, limited data are available for the targeting of both HER2 and AR...

Full description

Bibliographic Details
Main Authors: Zi-yan Yang, Jia-huan Huang, Bo Chen, Chun-wei Xu, Lei Lei, Xiao-jia Wang, Mei-yu Fang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
salivary duct carcinoma
tyrosine kinase inhibitor
pyrotinib
HER2 positive
targeted
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.559057/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.559057/full

Similar Items